Ningbo Scientz Biotechnology Co (BJSE:920685) Beneish M-Score: -2.52 (As of Aug. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920685 Ningbo Scientz Biotechnology Co Ltd BJSE:920685
73 GF Score
Price ¥12.18
GF Value ¥15.96
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Ningbo Scientz Biotechnology Co Beneish M-Score?

Ningbo Scientz Biotechnology Co BJSE:920685 73 Beneish M-Score is -2.52 as of Aug. 17, 2026. GuruFocus rates BJSE:920685 with a GF Score™ of 73/100 and a GF Value™ of ¥15.96 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 767 Medical Devices & Instruments companies, Ningbo Scientz Biotechnology Co ranks worse than 55.02% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.52 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Ningbo Scientz Biotechnology Co's Beneish M-Score or its related term are showing as below:

BJSE:920685' s Beneish M-Score Range Over the Past 10 Years
Min: -5.66   Med: -2.52   Max: -1.63
Current: -2.52

During the past 13 years, the highest Beneish M-Score of Ningbo Scientz Biotechnology Co was -1.63. The lowest was -5.66. And the median was -2.52.


Ningbo Scientz Biotechnology Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Ningbo Scientz Biotechnology Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ningbo Scientz Biotechnology Co Beneish M-Score Chart

Ningbo Scientz Biotechnology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -2.58 -5.66 -2.12 -2.78

Ningbo Scientz Biotechnology Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.73 -1.90 -2.72 -2.78 -2.52

BJSE:920685 vs ABT, SYK, MDT: Beneish M-Score Comparison

For the Medical Devices subindustry, Ningbo Scientz Biotechnology Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ningbo Scientz Biotechnology Co Beneish M-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ningbo Scientz Biotechnology Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Ningbo Scientz Biotechnology Co's Beneish M-Score falls into.


BJSE:920685
73GF Score
Ningbo Scientz Biotechnology Co Ltd BJSE:920685
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ningbo Scientz Biotechnology Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Ningbo Scientz Biotechnology Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1682+0.528 * 0.9781+0.404 * 0.9602+0.892 * 0.9921+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9049+4.679 * -0.026963-0.327 * 1.1564
=-2.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was ¥12.1 Mil.
Revenue was 34.892 + 55.553 + 43.022 + 38.488 = ¥172.0 Mil.
Gross Profit was 21.888 + 35.68 + 27.133 + 23.803 = ¥108.5 Mil.
Total Current Assets was ¥409.4 Mil.
Total Assets was ¥666.5 Mil.
Property, Plant and Equipment(Net PPE) was ¥183.4 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0.0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥11.6 Mil.
Total Current Liabilities was ¥68.5 Mil.
Long-Term Debt & Capital Lease Obligation was ¥5.1 Mil.
Net Income was 6.958 + 14.496 + 8.844 + 5.364 = ¥35.7 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ¥0.0 Mil.
Cash Flow from Operations was -13.255 + 38.59 + 16.423 + 11.875 = ¥53.6 Mil.
Total Receivables was ¥10.5 Mil.
Revenue was 32.661 + 59.394 + 41.823 + 39.447 = ¥173.3 Mil.
Gross Profit was 20.652 + 35.61 + 26.271 + 24.441 = ¥107.0 Mil.
Total Current Assets was ¥399.8 Mil.
Total Assets was ¥638.4 Mil.
Property, Plant and Equipment(Net PPE) was ¥165.1 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0.0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥12.9 Mil.
Total Current Liabilities was ¥57.2 Mil.
Long-Term Debt & Capital Lease Obligation was ¥3.7 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(12.12 / 171.955) / (10.458 / 173.325)
=0.070484 / 0.060338
=1.1682

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(106.974 / 173.325) / (108.504 / 171.955)
=0.617187 / 0.631002
=0.9781

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (409.358 + 183.386) / 666.507) / (1 - (399.756 + 165.076) / 638.419)
=0.110671 / 0.115264
=0.9602

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=171.955 / 173.325
=0.9921

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 165.076)) / (0 / (0 + 183.386))
=0 / 0
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(11.564 / 171.955) / (12.881 / 173.325)
=0.06725 / 0.074317
=0.9049

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((5.079 + 68.464) / 666.507) / ((3.686 + 57.228) / 638.419)
=0.110341 / 0.095414
=1.1564

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(35.662 - 0 - 53.633) / 666.507
=-0.026963

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Ningbo Scientz Biotechnology Co has a M-score of -2.52 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.52 mean?
Ningbo Scientz Biotechnology Co (BJSE:920685) has a Beneish M-Score of -2.52 as of Aug. 17, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Ningbo Scientz Biotechnology Co and its competitors. According to the industry distribution chart, Ningbo Scientz Biotechnology Co ranks #422 out of 767 companies in the Medical Devices & Instruments industry, placing it in the top 55%.
Is Ningbo Scientz Biotechnology Co's Beneish M-Score too high?
Ningbo Scientz Biotechnology Co's current Beneish M-Score is -2.52. Based on the distribution chart, Ningbo Scientz Biotechnology Co ranks #422 out of 767 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Ningbo Scientz Biotechnology Co has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ningbo Scientz Biotechnology Co's Beneish M-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Ningbo Scientz Biotechnology Co ranks #422 out of 767 companies for Beneish M-Score. This places Ningbo Scientz Biotechnology Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Ningbo Scientz Biotechnology Co and its competitors. Ningbo Scientz Biotechnology Co's current Beneish M-Score is -2.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ningbo Scientz Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Ningbo Scientz Biotechnology Co (BJSE:920685) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥15.96, compared to a current price of ¥12.18 — trading 23.7% below its estimated fair value. The current Beneish M-Score is -2.52. Ningbo Scientz Biotechnology Co's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Ningbo Scientz Biotechnology Co (BJSE:920685), the current Beneish M-Score is -2.52 as of Aug. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ningbo Scientz Biotechnology Co (BJSE:920685) Overvalued in 2026?

Based on GuruFocus' analysis, Ningbo Scientz Biotechnology Co stock appears to be undervalued. The current stock price of ¥12.18 is trading 23.7% below its estimated GF Value™ of ¥15.96. GuruFocus considers Ningbo Scientz Biotechnology Co to be Modestly Undervalued.

Key valuation signals for BJSE:920685:

  • Beneish M-Score: -2.52
  • GF Value™: ¥15.96 vs. price of ¥12.18 (23.7% below fair value)
  • GF Score™: 73/100 with 4 warning signs

No single metric tells the full story. See the BJSE:920685 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ningbo Scientz Biotechnology Co Business Description

Address No. 65 Mujin Road, Science and Technology Park, Zhejiang Province, Ningbo, CHN, 315010
Ningbo Scientz Biotechnology Co Ltd is involved in the Research and Development, production and sales of life science instruments.
73GF Score

Get the complete analysis for BJSE:920685

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥12.18
Price
¥15.96
GF Value